Recruiting NA INTERVENTIONAL 2-arm
NCT07001631
Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease (RELAX)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions
Pain Pain, Chronic Disease Sickle Cell Disease
Interventions
Eye Movement Desensitization and Reprocessing (EMDR)
Updated 1 time since 2025 Last updated: May 23, 2025 Started: Sep 20, 2024 Primary completion: Jul 1, 2026 Completion: Jul 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Pain and Pain, Chronic Disease and is currently actively recruiting participants. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Data source: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
For direct contact, visit the study record on ClinicalTrials.gov .